Page last updated: 2024-09-04

monodansylthiacadaverine and Leukemia, Myeloid, Acute

monodansylthiacadaverine has been researched along with Leukemia, Myeloid, Acute in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Andrew, G; Craddock, C; Crawley, C; Dillon, R; Freeman, S; Gilleece, M; Hodgkinson, A; Jackson, A; Khan, N; Krishnamurthy, P; Loke, J; Mason, J; McCarthy, N; Peniket, A; Potter, V; Protheroe, R; Salim, R; Siddique, S; Tholouli, E; Wilson, K1

Other Studies

1 other study(ies) available for monodansylthiacadaverine and Leukemia, Myeloid, Acute

ArticleYear
Posttransplant MRD and T-cell chimerism status predict outcomes in patients who received allografts for AML/MDS.
    Blood advances, 2023, 07-25, Volume: 7, Issue:14

    Topics: Allografts; Chimerism; Humans; Leukemia, Myeloid, Acute; Myelodysplastic Syndromes; T-Lymphocytes

2023